Prescription Required.
Is a glycopeptide antibiotic.
Treatment of serious infections caused by Grampositive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, and Enterococcus faecalis (certain strains).
Treatment of infections unresponsive to other antibiotics.
Takeo 400mg Injection (Teicoplanin) inhibits bacterial cell wall synthesis by binding to peptidoglycan precursors, preventing the formation of the bacterial cell wall, ultimately leading to bacterial cell death.
Store at room temperature (20-25°C). Protect from light and moisture. Discard any unused portion after the expiration date.
Dosage and frequency are determined by the severity of the infection and the patient's kidney function.
Teicoplanin is typically administered intravenously (IV) by slow infusion.
Specific dosing instructions will be provided by your physician or healthcare provider.
Infusionrelated reactions (e.g., flushing, hypotension, fever)
Nausea
Vomiting
Diarrhea
Rash
Pruritus (itching)
Renal impairment (rare but serious)
Consult your doctor. Alcohol may interact with some medications and should be discussed with your healthcare provider.
May cause dizziness or other side effects that could impair alertness. Avoid driving or operating machinery if affected.
Use only if clearly needed and benefits outweigh risks. Consult your doctor.
Dosage adjusted according to weight and age. Consult your physician.
Dosage adjustment is required in patients with impaired kidney function.
Teicoplanin is primarily excreted by the kidneys. Liver function should be monitored, but dose adjustments are typically not needed based solely on liver function.
This information is for general knowledge and should not be considered medical advice. Always consult your physician or other qualified healthcare professional for any questions about your medical condition or treatment.
Refer to the official prescribing information from your pharmacy for detailed and accurate information
